Abstract
While for years clinicians have used cuff pressure to assess patients’ cardiovascular risk, recent evidences has shown that aortic pressure, or more specifically aortic systolic and aortic pulse pressures, have a better prognostic value to predict cardiovascular events and mortality. This led to the emergence of multiple methods and devices to assess aortic pressure non-invasively. Some use scaled waveforms measured at the carotid level with tonometry, or ultrasounds. Others use transfer function or mathematical modelling from radial or brachial traces acquired from volume plethsymography or applanation tonometry. Not all these techniques are equivalent and most of them have the major flaw of using brachial cuff pressure to scale their results. The purpose of this review is to present the strengths and weaknesses of techniques and various commercial devices to estimate aortic systolic pressure.
Keywords: Central pressure, aortic pressure, applanation tonometry, echotracking, transfer function, pulse wave analysis.
Current Pharmaceutical Design
Title:Non-invasive Estimation of Aortic Blood Pressures: A Close Look at Current Devices and Methods
Volume: 21 Issue: 6
Author(s): Sandrine Millasseau and Davide Agnoletti
Affiliation:
Keywords: Central pressure, aortic pressure, applanation tonometry, echotracking, transfer function, pulse wave analysis.
Abstract: While for years clinicians have used cuff pressure to assess patients’ cardiovascular risk, recent evidences has shown that aortic pressure, or more specifically aortic systolic and aortic pulse pressures, have a better prognostic value to predict cardiovascular events and mortality. This led to the emergence of multiple methods and devices to assess aortic pressure non-invasively. Some use scaled waveforms measured at the carotid level with tonometry, or ultrasounds. Others use transfer function or mathematical modelling from radial or brachial traces acquired from volume plethsymography or applanation tonometry. Not all these techniques are equivalent and most of them have the major flaw of using brachial cuff pressure to scale their results. The purpose of this review is to present the strengths and weaknesses of techniques and various commercial devices to estimate aortic systolic pressure.
Export Options
About this article
Cite this article as:
Millasseau Sandrine and Agnoletti Davide, Non-invasive Estimation of Aortic Blood Pressures: A Close Look at Current Devices and Methods, Current Pharmaceutical Design 2015; 21 (6) . https://dx.doi.org/10.2174/1381612820666141023163748
DOI https://dx.doi.org/10.2174/1381612820666141023163748 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Tissue-Specific Glucocorticoid Reactivating Enzyme, 11β-Hydroxysteoid Dehydrogenase Type 1 (11β-HSD1) - A Promising Drug Target for the Treatment of Metabolic Syndrome
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Alzheimers Disease: From Pathogenesis to Disease-Modifying Approaches
CNS & Neurological Disorders - Drug Targets The Synthesis of Coenzyme Q10
Current Organic Chemistry Development of Nitric Oxide Donors for the Treatment of Cardiovascular Diseases
Cardiovascular & Hematological Agents in Medicinal Chemistry Nitric Oxide and L-Arginine Deficiency in Cystic Fibrosis
Current Pharmaceutical Design A Perspective on Monoamine Oxidase Enzyme as Drug Target: Challenges and Opportunities
Current Drug Targets Mediterranean Diet in Predementia and Dementia Syndromes
Current Alzheimer Research New Challenges for ACE-Inhibitors in Vascular Diseases
Drug Design Reviews - Online (Discontinued) New Strategies for Managing Anemia of Chronic Kidney Disease
Cardiovascular & Hematological Agents in Medicinal Chemistry Aqueous Extract of <i>Cola nitida</i> and <i>Garcinia kola</i> Synergistically Enhances Hippocampal-hypothalamic Glutamate and Na+ /K+ -ATPase Activity in Male Wistar Rats
Current Drug Discovery Technologies C-type Natriuretic Peptide (CNP): Cardiovascular Roles and Potential as a Therapeutic Target
Current Pharmaceutical Design Supplementation of Creatine and Ribose Prevents Apoptosis and Right Ventricle Hypertrophy in Hypoxic Hearts
Current Pharmaceutical Design Recent Patents in siRNA Delivery Employing Nanoparticles as Delivery Vectors
Recent Patents on DNA & Gene Sequences Targeted-Therapy in Advanced Renal Cell Carcinoma
Current Medicinal Chemistry Hormonal Status Modifies Renin-Angiotensin System-Regulating Aminopeptidases andVasopressin-DegradingActivity in the Hypothalamus-Pituitary-Adrenal Axis of Female Mice
Medicinal Chemistry Patient Engagement in Randomized Controlled Tai Chi Clinical Trials among the Chronically Ill
Reviews on Recent Clinical Trials Use of Diverse Chemometric and Validation Methods to Accurately Predict Human Urotensin-II Receptor Antagonist Activity
Current Computer-Aided Drug Design Zwitterionic Imidazolium Salt: An Efficient Organocatalyst for the One-Pot Synthesis of 5,6-Unsubstituted 1,4-Dihydropyridine Scaffolds
Current Organocatalysis Angiogenesis Inhibitors and Vascular Disrupting Agents in Non-Small Cell Lung Cancer
Current Medicinal Chemistry Gene Therapy Targeting Inflammation in Atherosclerosis
Current Pharmaceutical Design